Understanding and Managing Drug-Drug Interactions
Received Date: Oct 01, 2025 / Published Date: Oct 29, 2025
Abstract
Thiscollectionofstudiesaddressesthemultifacetedchallengesofdrug-druginteractions(DDIs)acrossdiversepatientpopulations
and therapeutic areas. It highlights the foundational role of pharmacogenetics in predicting DDIs and the significant influence of
cytochrome P450 enzymes. Specific concerns are raised regarding oral anticoagulants, HIV antiretroviral therapy, cancer treatments,
central nervous system medications, and drug management in the elderly and in chronic kidney disease patients. Proton pump
inhibitors are also identified as potential sources of DDIs. The reviews advocate for proactive management strategies, including
personalized dosing, careful drug selection, comprehensive medication reviews, and interprofessional collaboration, particularly in
high-risk settings like critical care.
Citation: 脗聽M脙录ller DA (2025) Understanding and Managing Drug-Drug Interactions. Int J Res Dev Pharm L Sci 11: 295.
Copyright: 漏 2025 Dr. Anne M眉ller This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 416
- [From(publication date): 0-0 - Apr 04, 2026]
- Breakdown by view type
- HTML page views: 356
- PDF downloads: 60
